// App-Quantinova.ai

2112-309 : CLINICAL IMPACT OF SECOND-GENERATION EVEROLIMUS-ELUTING STENTS COMPARED WITH FIRST-GENERATION DRUG-ELUTING STENTS IN DIABETIC PATIENTS UNDERGOING MULTIVESSEL PERCUTANEOUS CORONARY INTERVENTION

Researchers

Presenter

  • Lakshmana Pendyala

Principal Investigators

  • Joshua Loh

  • Rebecca Torguson

  • Lowell Satler

  • Sa'ar Minha

  • Nevin Baker

  • Ricardo Escarcega Alarcon

  • Hideaki Ota

  • Augusto Pichard

  • Ron Waksman

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Multi-vessel disease

  • Left main disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved